{"name": "Arresto BioSciences",
 "permalink": "arresto-biosciences",
 "crunchbase_url": "http://www.crunchbase.com/company/arresto-biosciences",
 "homepage_url": "http://www.arresto.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "(650) 352 5564",
 "description": "",
 "created_at": "Tue Dec 21 05:03:07 UTC 2010",
 "updated_at": "Tue Dec 21 05:03:06 UTC 2010",
 "overview": "\u003Cp\u003EArresto Biosciences, Inc., a biotechnology company, develops medicines to treat cancer and fibrotic diseases by targeting molecules from the extracellular matrix. The company was incorporated in 2007 and is based in Palo Alto, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       83],
      "assets/images/resized/0011/4868/114868v1-max-150x150.png"],
     [[250,
       139],
      "assets/images/resized/0011/4868/114868v1-max-250x250.png"],
     [[387,
       216],
      "assets/images/resized/0011/4868/114868v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Peter",
      "last_name": "Van Vlasselaer",
      "permalink": "peter-van-vlasselaer",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 225000000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020101221e6cl0005l\u0026r=Rss\u0026s=DJFVLS",
   "source_description": "  Gilead Sciences To Acquire Arresto BioSciences For $225M Cash",
   "acquired_year": 2010,
   "acquired_month": 12,
   "acquired_day": 20,
   "acquiring_company":
    {"name": "Gilead Sciences",
     "permalink": "gilead-sciences",
     "image":
      {"available_sizes":
        [[[150,
           41],
          "assets/images/resized/0009/1771/91771v1-max-150x150.png"],
         [[185,
           51],
          "assets/images/resized/0009/1771/91771v1-max-250x250.png"],
         [[185,
           51],
          "assets/images/resized/0009/1771/91771v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3183 Porter Drive",
    "address2": "",
    "zip_code": "94304 ",
    "city": "Palo Alto",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}